StonvexLoading…
StonvexStonvexStonvexCore line items from AMTD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $101.22M | $80.46M | $130.91M | $105.36M |
Operating Income | $68.82M | $55.22M | $157.70M | $173.87M |
Net Income | $67.25M | $53.58M | $153.38M | $160.47M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $2.30B | $2.07B | $1.49B | $1.06B |
Total Liabilities | $385.38M | $369.89M | $193.02M | $58.31M |
Cash & Equivalents | $51.07M | $62.87M | $120.23M | $138.30M |
Free Cash Flow OCF − CapEx | $17.09M | $5.15M | $39.91M | $26.62M |
Shares Outstanding | Not available | Not available | Not available | Not available |